NPI 1659850212: Open Payments
NPI 1659850212. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 15 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $85 |
| Exact Sciences Corporation | 2 | $57 |
| Lilly USA, LLC | 3 | $56 |
| PFIZER INC. | 2 | $35 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Boston Scientific Corporation | 1 | $23 |
| ABBVIE INC. | 1 | $18 |
Products named: Wegovy, The Cologuard Plus Collection Kit, MOUNJARO, ELIQUIS, TZIELD, WATCHMAN FLX, QULIPTA, Ozempic.
